Delivery Order SPE2DB20D3103-SPE2DB25FQ3A3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitive delivery order, with a ceiling value of $1,066.35 and firm fixed pricing, represents a continuation of the contractor's pharmaceutical supply services to federal military and healthcare systems. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 for a ceiling value of $1,949.17. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing and is scheduled for completion by August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 on September 15, 2025, with a ceiling value of $4,047.00 and an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,663.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count) with a completion date of September 2, 2025. This contract is classified as a non-set-aside award, meaning it was competitively awarded without restrictions on eligible bidders. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $8,233.44 delivery order to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets (20-count packages) under a firm fixed-price contract. The order, issued on September 13, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.27 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of April 22, 2025, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a $1,638.24 delivery order to AmerisourceBergen Drug Corp for Cefpodixome 200 mg tablets (20-count units) under a firm fixed-price contract, with an ultimate completion date of August 11, 2025. This award utilizes no set-aside designation and represents a competitive procurement for pharmaceutical supplies. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cefpodoxime 200 mg Tablets. The $1,161.04 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $961.84 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 200mg cefpodoxime tablets. The single delivery order is for 20 tablets and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 29, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3A3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,016.67 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen regularly fulfills pharmaceutical procurement requirements across multiple therapeutic domains to support military and federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to meet open competition requirements and deliver critical medical commodities to defense and civilian government customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/15/25 |